IllExcor Therapeutics LLC
Illexcor-Home
Richmond, United States · Founded 2020
- Headquarters
- Richmond, Virginia
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- illexcor.com
- Last Round
- GrantMar 2025
- Rounds
- 2
About
IllExcor Therapeutics is a pre-clinical stage biopharmaceutical company focused on small molecule drug discovery for sickle cell disease and related conditions. Their lead compound ILX002 targets sickle cell disease through a novel prodrug approach, supported by NIH SBIR Phase I funding. The company is developing an oral drug pipeline for blood disorders.
Summary
IllExcor Therapeutics LLC is a Biotech company based in Richmond, United States, founded in 2020. Its most recent funding was a Grant round in Mar 2025. Investors include Department of Health and Human Services.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.